Search Intelligence

“Allocating $105M of a $150M raise to human clinical trials versus $20M for AI model training underscores that in computational biotech, wet-lab survival data still dictates unit economics.”

“Thyme Care is using its navigation software as a wedge to roll up the far more lucrative clinical trial and biosimilar supply chains.”

“AstraZeneca is essentially renting the upside of a Keytruda competitor for $2B rather than buying Summit outright and holding the bag if clinical trials hit a wall.”

“Big pharma dropping massive checks on smaller developers usually means their internal oncology pipeline is something they're losing faith in.”

“So a $111.7 million IPO is barely enough capital to get a phase 2 oncology trial paid for.”